EDGAR Filing Documents for 0001193125-22-066309

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001193125-22-066309

Filing Date

2022-03-04

Accepted

2022-03-04 17:13:34

Documents

Effectiveness Date

2022-03-04

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	d239385ds8.htm	S-8	46772
2	EX-5.1	d239385dex51.htm	EX-5.1	11982
3	EX-23.1	d239385dex231.htm	EX-23.1	1604
4	EX-FILING FEES	d239385dexfilingfees.htm	EX-FILING FEES	12606
5	GRAPHIC	g239385g15x24.jpg	GRAPHIC	2418
	Complete submission text file	0001193125-22-066309.txt		77448

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263321 | Film No.: 22715201
SIC: 2834 Pharmaceutical Preparations